Catheter Precision, Inc. VTAK

0.15 (0.01) (6.25%) as of 25 Sep
Market cap
$3.0M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(115.04%) (189.53%) (186.69%) (230.26%)

+8 more TTM periods

ROA
(43.65%) (54.03%) (78.77%) (84.99%)
ROIC
(64.41%) (104.18%) (137.06%) (157.44%)
Return on Tangible Assets
125.99% 88.12% 497.63% 796.52%
Average Days of Receivables
22.87 85.98 69.08 61.50
Free Cash Flow per Share
(3.39) (4.00) (7.69) (7.32)
Free Cash Flow
(9.37) (8.77) (8.31) (9.66)
Capital Expenditures
(0.02) (0.01) (0.02) (0.02)
Piotroski F-Score
3.00 4.00 3.00 4.00
Other line items
Cash ROIC
(42.00%) (68.33%) (84.51%) (98.43%)
Accounts Receivable Turnover
16.30 6.40 7.28 6.35
Accounts Payable Turnover
0.89 0.11 0.07 0.06
Inventory Turnover
14.72 1.41 1.06 1.64
Average Days of Payables
527.63 4,189.73 8,644.13 7,293.24
Days of Inventory on Hand
32.09 240.74 498.25 229.81
Tax Rate
(0.05) (0.08) (0.09) (0.10)
Research and Development Expense of Revenue
46.74% 81.95% 105.25% 85.62%
Selling, General and Administrative Expense of Revenue
635.98% 1,006.23% 1,474.36% 1,700.96%
Share Based Compensation of Revenue
25.01% 28.07% 41.27% 37.95%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.69 0.54 0.48 0.43
Depreciation/Fixed assets
17.13 15.99 33.05 29.43
Capex/Depreciation
(0.01) (0.01) (0.01) (0.01)
Revenue per Share
0.69 0.51 0.76 0.55
Operating CF per Share
(3.38) (3.99) (7.68) (7.31)
Capex per Share
(0.01) (0.01) (0.02) (0.01)
Capex to Sales
0.01 0.01 0.02 0.02
Net Profit Margin
(711.49%) (1,460.20%) (2,098.05%) (3,039.86%)

Fold the line items

Columns are period end dates